Vilon: Thymus & Immune System Bioregulator Research
Dipeptide bioregulator for thymic and immune function
Source: https://indexalabs.com/blog/vilon-bioregulator-thymus-immune-research Abstract: Vilon (Lys-Glu) is a synthetic dipeptide bioregulator targeting the thymus gland. Research focuses on its potential to support immune function, T-cell development, and thymic tissue regeneration in aging and immunocompromised models.
1. Overview & Background
1.1 What is Vilon? Vilon is the shortest Khavinson bioregulator—a dipeptide (Lys-Glu) designed to support thymus gland function and immune system regulation.
1.2 Target Tissue Primary: Thymus gland and thymocytes Secondary: T-lymphocytes and broader immune system
1.3 Thymic Involution The thymus undergoes significant age-related shrinkage (involution), reducing T-cell production. Vilon research focuses on counteracting this decline.
2. Mechanisms of Action
2.1 Thymic Gene Expression Studies suggest Vilon may modulate expression of genes involved in thymocyte development and thymic epithelial cell function.
2.2 T-Cell Development Research indicates potential support for T-cell maturation and differentiation processes.
2.3 Cytokine Modulation May influence production of thymic hormones and immune-regulatory cytokines.
2.4 Thymic Architecture Some studies suggest effects on maintaining thymic structural integrity in aging models.
3. Research Evidence
3.1 Aging Studies Animal research demonstrates improved thymic weight and cellularity in aged subjects.
3.2 Immune Function Studies show enhanced T-cell counts and immune response parameters.
3.3 Stress Models Protective effects observed in immunosuppression and stress-induced immune decline models.
3.4 Longevity Research Some studies associate Vilon treatment with lifespan extension in animal models.
4. Research Protocols
4.1 Vial Size Available in 20mg vials for research applications.
4.2 Synergistic Research Often studied with Thymalin and other immune-supporting peptides.
4.3 Seasonal Timing Some protocols time administration with seasonal changes or immune challenges.
4.4 Cycle Duration Standard research cycles of 10-20 days with multi-month intervals.